Belgian Cancer Registry: Stereotactic Body Radiation Therapy

The 'Innovative Radiotherapy Techniques' registrationproject is an initiative of the 'Rijksinstituut voor ziekte- en invaliditeitsverzekering' (National Institute for Sickness and Invalidity Insurance) (RIZIV/INAMI) in association with the radiotherapy services that use the following innovative radiotherapy technique: Stereotactic Body Radiation Therapy (SBRT). The main objective of this registration study and the limited early research funding is to examine the conditions under which and the fee for which innovative radiotherapy techniques will be included in the nomenclature for the medical services. Radiotherapy departments that want to participate in this project must sign the convention that the centre received from the RIZIV/INAMI. By signing this document they agree to treat patients from pre-determined target groups with the innovative radiotherapy techniques cited and also register the necessary clinical data, for a period of four years via temporary research funding. The clinical data must be registered by the radiotherapy service after the treatment in one of the online registration modules specially developed by the Belgian Cancer Registry for this purpose: the SBRT module or the APBI and Boost module.‘创新性放射治疗技术’登记项目，由比利时国家疾病与残疾保险研究所（Rijksinstituut voor ziekte- en invaliditeitsverzekering，简称RIZIV/INAMI）联合采用下述创新性放射治疗技术——立体定向体部放射治疗（Stereotactic Body Radiation Therapy，SBRT）的放射治疗服务机构共同发起。 本登记研究配套的有限额度早期研究资助，其核心目标为探究创新性放射治疗技术纳入医疗服务术语体系的适用条件与收费标准。 有意参与本项目的放射治疗科室，需签署该中心从RIZIV/INAMI处获取的合作协议。签署该文件后，科室须承诺在四年临时研究资助周期内，使用前述创新性放射治疗技术为预先划定的目标人群患者提供治疗，并完成必要的临床数据登记。临床数据需由放射治疗服务机构在患者治疗结束后，通过比利时癌症登记处专为该项目开发的在线登记模块填报，具体涵盖SBRT模块以及APBI（Accelerated Partial Breast Irradiation，加速部分乳腺照射）与推量照射模块。